It might help if more emphasis is given to the fact that this is testing a GP led GA rather than simply GA. It was only after reading the discussion that it was really clear that the purpose of the study was to test GA in the primary care setting carried out by nongeriatricians. Placing the argument that geriatrician led care is not necessarily going to be feasible at a population level in the background section would help to set the scene, as would a elaboration around the possible limitations of this type of GA (there is no mention of use of a multi-disciplinary team including allied health professionals).
It is not clear if the authors plan to use the co-morbidity data to give a measure of frailty to compare groups at baseline (or to do any subgroup analysis). If so, some discussion on the reason for this choice over other methods for identifying frailty is required.
The tense it is written in changes part way through the methods section -the first half is in the past tense and the second half in the future. It might read better if it is all in the future tense as it is a protocol paper, even if some of the work has been started.
Will there be any measurement of treatment fidelity (review of assessments and care plans)?
The term autonomy (use on pg 12, line 41 might be replaced with independence (and where it features in the figures / tables).
It might be worth explaining when describing the primary outcome measure, that this intervention is expected to reduce mortality. It could be argued that in some cases GA in frail patients may result in withdrawal of invasive treatment and an emphasis on comfort that may reduce life expectancy. If the authors think this is unlikely to happen because their chosen cohort is too well, this needs to be explained.
It is clearly impossible for the participants and care providers to be blinded to trial arm. The authors do not explain why they have not chosen to use non-blinded assessors for measuring outcome data. This leaves the study at risk of bias and needs an explanation A reference for the ICC prediction is required.
Some of the medical conditions in the table may have been lost in translation: chronic cytopenias shortcomings Chronic arterial ischemic events with Hemoglobinopathies, hemolysis, chronic constitutional and acquired severe Inherited metabolic diseases requiring prolonged treatment specialist
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GENERAL COMMENTS
Many thanks for your submission which I read with interest. This is a well-written and logically planned study. There were however a few points that I felt needed addressing before publication can be considered. 1) The term geriatric assessment (GA) is somewhat confusing. The typical term used in the literature (and many of the references you cite in relation to GA) is comprehensive geriatric assessment (CGA). There is already confusion amongst non-geriatricians as to what CGA is (and isn't). To avoid further muddying of the waters I'd suggest the authors consider amending the terminology to be more consistent with the widely used CGA.
2) Given the evidence that exists for (C)GA I'd suggest rephrasing the reference to "alleged" benefits of GA (page 10, paragraph 3)
3) The reference to the use of a questionnaire to assess "selfreported overall satisfaction from participating GPs" is somewhat opaque. There needs to be greater detail in relation to the content and structure of the questionnaire, how this was developed, whether it was piloted and what the plan for analysis of questionnaire data will be. This is an important area to provide additional detail on, since "satisfaction with the intervention" is stated as being a secondary objective for the study. Furthermore, this objective refers to considering nurses' satisfaction too, yet there is no reference to asking nursing staff to complete the questionnaire? This needs further clarification
VERSION 1 -AUTHOR RESPONSE
Answers to reviewers -R1 January 17th, 2018 Manuscript: "Efficacy of nurse-led and General Practitioner-led comprehensive geriatric assessment in primary care: Protocol of a pragmatic three-arm cluster randomized controlled trial (CEpiA study)"
We sincerely thank the editors and reviewers for their careful review and comments and hope that the manuscript is now suitable for publication in BMJ Open. Our responses are inserted (in blue in the file attached) after each of the reviewers' comments. The corresponding corrections have been made in the revised manuscript using Word's track changes feature. Yours faithfully, Emilie Ferrat
Reviewer: 1 -This in the most part is a well written protocol -there are a few aspects which could improve clarity.
We thank the reviewer for this comment.
-It might help if more emphasis is given to the fact that this is testing a GP led GA rather than simply GA. It was only after reading the discussion that it was really clear that the purpose of the study was to test GA in the primary care setting carried out by non-geriatricians. Placing the argument that geriatrician led care is not necessarily going to be feasible at a population level in the background section would help to set the scene, as would a elaboration around the possible limitations of this t ype of GA (there is no mention of use of a multi-disciplinary team including allied health professionals).
We agree with the reviewer's comment and have consequently modified the introduction section, as following: "(…) It has been found useful to characterize functional and health impairments in older patients, particularly in the geriatric oncological setting. [11 12] However, a large implementation of geriatrician led CGA at the population level may prove difficult due to feasibility constraints, thus requiring the involvement of non-geriatricians health professionals." In addition, we added to the methods section the following elements: "As showcased during the seminar, a specific instrument will be used by participating GPs and nurses to conduct a CG A adapted to primary care for non-geriatricians healthcare professionals and then build a personalized care plan of actions (…) Information will be collected on the involvement of other health professionals -including physiotherapists, dietitians, psychologists and social workers -but modalities of such multidisciplinary collaborations for implementing the PCP will not be formalized in the protocol and left to the GP's discretion. Finally, we slightly modified the discussion section relating to study lim its, as follows: "Although the CGA has been adapted to the primary care setting for non-geriatricians healthcare professionals, preliminary tests suggest that it remains time-consuming" -It is not clear if the authors plan to use the co-morbidity data to give a measure of frailty to compare groups at baseline (or to do any subgroup analysis). If so, some discussion on the reason for this choice over other methods for identifying frailty is required.
As noted by the reviewer, co-morbidity data will be collected to provide minimal information for all three randomized groups regarding this important component of frailty. Indeed, this information will allow the comparison of baseline characteristics across groups, as well as the conduct of subgroup analyses to test the robustness of the results found in the whole population and to identify potentially modified effects depending on levels of comorbidity. However, we chose not to rely on pre-existing specific instruments for detecting frailty (e.g. G8, Groningen Frailty Index, VES-13 ...), so as to limit the organized collection of data directly relating to frailty in the control group and prevent a possible modification of practices in GP's from this group who could be influenced by such frailty -oriented data collection inducing a training or Hawthorne effect. The fact that there is currently no consensus on the most appropriate tool to use for detecting frailty was also considered in our decision not to rely on one given frailty instrument. Those elements have been clarified in the methods section of the revised manuscript, as follows: "The following data will be collected for patients for descriptive analyses, comparisons of baseline characteristics across groups and/or verifying eligibility criteria: demographic data, marital status, type and date of onset of comorbidities (i.e., cardiovascular risk factors, history of cancer and/or cardiovascular, metabolic, respiratory, kidney, liver, musculoskeletal and neuropsychological chronic diseases), current treatment, referral motive, history of hospitalization and/or emergency admissions before inclusion, and type and date of first qualification for the long-term illness. Information on comorbidities will be further used in subgroup analyses to identify potentially modified effects depending on levels of comorbidity. No specific instrument will be used for identifying frailty in the control group to limit the organized collection of data directly relating to frailty which could induce modifications of practices in GP's by training or Hawthorne effect." -The tense it is written in changes part way through the methods section -the first half is in the past tense and the second half in the future. It might read better if it is all in the future tense as it is a protocol paper, even if some of the work has been started.
In accordance with the reviewer's comment, we modified the methods section to systematically use the future tense. We only kept in the present perfect the following sentence in the methods section relating to randomization, relating to the number of GP practices willing to participate at the time of paper's writing: "At the time of the paper's writing, agreement to participate has been obtained from 40 GP practices".
-Will there be any measurement of treatment fidelity (review of assessments and care plans)?
Actual list of prescribed medications is collected during the 3 visits (M0, M6 and M12) by the GP with a prescription copy stored in the CRF. In addition, the following information will also be collected at M6 and M12: -"Have the results (of the PCP) been achieved? (Yes, fully ; Yes, partially ; and No)" [ Figure 3 ] -"Since the last consultation / inclusion visit, have aid and / or care actions been triggered? (yes, no, do not know). If Yes, specify which ones below (the same list as proposed in the figure 3 », corresponding to time spans between M0 and M6 and between M6 and M12 [CRF, data not shown] To account for the reviewer's comment, we added the following sentence to the methods section: « Information on the level of achievement of PCP objectives will be collected in the CRF at M6 and M12 (fully/partially/no). » -The term autonomy (use on pg 12, line 41 might be replaced with independence (and where it features in the figures / tables).
We agree that the term 'autonomy' was not the most appropriate and consequently replaced it by « functional independence », commonly used in the literature.
-It might be worth explaining when describing the primary outcome measure, that this intervention is expected to reduce mortality. It could be argued that in some cases GA in frail patients may result in withdrawal of invasive treatment and an emphasis on comfort that may reduce life expectancy. If the authors think this is unlikely to happen because their chosen cohort is too well, this needs to be explained.
We thank the reviewer for this relevant comment. Indeed, the implementation of CGA may induc e the reduction or withdrawal of invasive therapeutic modalities in highly vulnerable patients (e.g. hospitalized older patients with cancer), thus possibly impacting negatively short term vital prognosis. Alternatively, our study population is focused on older subjects with a moderate level of frailty, excluding those with a life expectancy judged by the GP to be < 1 year and/or currently institutionalized (i.e., nursing home). We therefore anticipate beneficial effects of our CGA -based intervention on (morbi)mortality thanks to the initiation of new treatments guided by CGA findings. We consequently added to the methods and discussion sections the following sentences: -Methods (Measures): "Because the study population is focused on older subjects with a moderate level of frailty, i.e. excluding those with a life expectancy less than a year and/or currently institutionalized, beneficial effects on morbimortality are expected from the intervention thanks to the initiation of new treatments guided by CGA findings. The primary endpoint is therefore a composite of any of the following events at 12 months (…)" -Discussion: "This cluster randomized trial in three parallel groups will provide robust evidence about the benefits on morbimortality of a pragmatic intervention to improve the management of older patients with chronic conditions." -It is clearly impossible for the participants and care providers to be blinded to trial arm. The authors do not explain why they have not chosen to use non-blinded assessors for measuring outcome data. This leaves the study at risk of bias and needs an explanation We acknowledge the need for clarification of this important point. The primary outcome is based on the collection of objective and relatively easy-to-collect endpoints (mortality / hospitalization / institutionalization). Those elements will be primarily collected by GPs but thoroughly checked by clinical research technicians on the basis of available hospital stay reports, while vital status will be directly assessed from public records office. These elements have been clarified in the methods and discussion sections, as follows: Methods: "CRFs will be collected and monitored for consistency and missing data by clinical research technicians (CRTs) at M6 and M12 based on available hospital stay reports. Vital status will be determined from public records office." Discussion (study limits): "Finally, information on the outcomes will be collected by GPs who will be unblinded to the intervention. The potential resulting classification bias will however be limited, considering the objective nature of the endpoints analyzed (mortality, hospitalizations, institutionalization), the thorough verification of the CRF by clinical research technicians based on available hospital stay reports, and the direct use of public records office for determining vital status." -A reference for the ICC prediction is required.
We agree with the reviewer's comment. Since no previous study has been published to our knowledge focusing on the same population and with similar endpoints, we used data from a recent cluster randomized trial by Suijker et al, who reported an ICC of 0.003 for the Katz ADL index using a two-level model (general practice, participant) in community -dwelling older persons. For the present study, a more conservative ICC of 0.01 was retained. The methods section relating to sample size calculation has been modified to include the corresponding reference as well as an additional methodological reference for the ICC, as follows: We thank the reviewer for this notification. The list of the long-term illnesses has been revised (supplementary Table S1 ).
Reviewer 2 -This is a well-written and logically planned study. There were however a few points that I felt needed addressing before publication can be considered. We thank the reviewer for this comment.
1) The term geriatric assessment (GA) is somewhat confusing. The typical term used in the literature (and many of the references you cite in relation to GA) is comprehensive geriatric assessment (CGA). There is already confusion amongst non-geriatricians as to what CGA is (and isn't). To avoid further muddying of the waters I'd suggest the authors consider amending the terminology to be more consistent with the widely used CGA.
We followed the reviewer's suggestion and systematically replaced the term GA by "CGA".
We have modified the sentence as follows: « The seminars focus on general principles and reported benefits of CGA (…) »
3) The reference to the use of a questionnaire to assess "self-reported overall satisfaction from participating GPs" is somewhat opaque. There needs to be greater detail in relation to the content and structure of the questionnaire, how this was developed, whether it was piloted and what the plan for analysis of questionnaire data will be. This is an important area to provide additional detail on, since "satisfaction with the intervention" is stated as being a secondary objective for the study. Furthermore, this objective refers to considering nurses' satisfaction too, yet there is no reference to asking nursing staff to complete the questionnaire? This needs further clarification.
We agree with the reviewer on the need for clarification of the origin and use of the questionnaire relating to satisfaction. As mentioned in the introduction and noted by the reviewer, the third secondary objective is to describe GPs' and nurses' satisfaction with the intervention in its two modalities. We consequently added the following elements to the methods section to improve clarity: "Feasibility, appropriation and satisfaction from the intervention will be assessed for descriptive purpose in GPs (arms 1 and 2) and nurses (arm 1) through an ad hoc self-reported questionnaire collected at end of study. This questionnaire was developed by the study steering committee and comprises 34 multiple-choice items addressing usual practices in management and follow-up of older patients, feasibility aspects, appropriation and satisfaction from the intervention, including the perceived utility of the proposed CGA and PCP, and comprising a free comment section.
Comprehension and time for completion was tested beforehand in one nurse and three GPs not participating to the study.
